HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenji Shiratori Selected Research

alpha-MSH

8/2004Anti-inflammatory effects of alpha-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor.
1/2004Inhibition of endotoxin-induced uveitis and potentiation of cyclooxygenase-2 protein expression by alpha-melanocyte-stimulating hormone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenji Shiratori Research Topics

Disease

12Uveitis
09/2006 - 06/2003
9Inflammation (Inflammations)
09/2006 - 06/2003
3Retinoblastoma (Glioblastoma, Retinal)
03/2006 - 08/2005
2Cataract (Cataracts)
03/2007 - 06/2006
2Retinal Detachment (Retinal Detachments)
03/2006 - 05/2004
2Necrosis
02/2006 - 10/2005
1Cardiovascular Diseases (Cardiovascular Disease)
09/2006
1Atopic Dermatitis (Atopic Eczema)
07/2006
1Behcet Syndrome (Behcet's Syndrome)
07/2006
1Macular Degeneration (Age-Related Maculopathy)
06/2006
1Eye Diseases (Eye Disease)
06/2006
1Retinal Neoplasms
03/2006
1Neoplasms (Cancer)
11/2005
1Melanoma (Melanoma, Malignant)
09/2005
1Neovascular Glaucoma
09/2005
1Anterior Uveitis
08/2004

Drug/Important Bio-Agent (IBA)

12EndotoxinsIBA
09/2006 - 06/2003
6Proteins (Proteins, Gene)FDA Link
02/2006 - 10/2003
5LipopolysaccharidesIBA
05/2006 - 06/2003
3NF-kappa B (NF-kB)IBA
09/2006 - 02/2006
3CytokinesIBA
07/2006 - 08/2004
3Proliferating Cell Nuclear Antigen (PCNA)IBA
03/2006 - 05/2004
3Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2006 - 08/2004
2AntibodiesIBA
03/2006 - 05/2004
2Threonine (L-Threonine)FDA Link
03/2006 - 08/2005
2Cyclin D1IBA
03/2006 - 05/2004
2ChemokinesIBA
02/2006 - 08/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2006 - 10/2005
2astaxanthine (astaxanthin)IBA
02/2006 - 06/2003
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2005 - 01/2004
2alpha-MSHIBA
08/2004 - 01/2004
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
03/2007
1Oxidants (Oxidizing Agents)IBA
03/2007
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
09/2006
1Captopril (Capoten)FDA LinkGeneric
09/2006
1Macrophage Migration-Inhibitory FactorsIBA
07/2006
1LuteinIBA
06/2006
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
03/2006
1Serine (L-Serine)FDA Link
03/2006
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
03/2006
1Dinoprostone (PGE2)FDA Link
02/2006
1Carotenoids (Carotene)IBA
02/2006
1paraform (paraformaldehyde)IBA
11/2005
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2005
1fucoxanthinIBA
10/2005
1ProstaglandinsIBA
10/2005
1Thymidine PhosphorylaseIBA
09/2005
1Cyclin-Dependent Kinase Inhibitor p27IBA
08/2005
1naringinIBA
08/2005
1naringeninIBA
08/2005
1Prednisolone (Predate)FDA LinkGeneric
08/2004
1Ginkgo biloba extract (Rokan)IBA
08/2004
1NeuropeptidesIBA
08/2004
1Glutamic Acid (Glutamate)FDA Link
05/2004
1Ligases (Synthetase)IBA
05/2004
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2004
1Peptides (Polypeptides)IBA
10/2003

Therapy/Procedure

1Drug Therapy (Chemotherapy)
07/2006
1Aftercare (After-Treatment)
03/2006